Skip to content

Intervention of transcranial photobiomodulation for children with autism spectrum disorder

Individualized multimodal neuroregulation technology for children with autism spectrum disorder

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125373
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Experimental Group:transcranial photobiomodulation, neurofeedback training
Control group:sham transcranial photobiomodulation, sham neurofeedback training

Sponsors

Ningbo Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 3 - 12 years old, gender not restricted; 2. The guardian of the child must provide informed consent and sign the consent form; 3. All ASD children are diagnosed as autism by experienced doctors based on the DSM-V standards.

Exclusion criteria

Exclusion criteria: 1. The child has other brain development disorders such as ADHD, RETT syndrome and developmental delay; 2. The child has serious physical diseases, a history of brain trauma, and a history of epilepsy; 3. Received non-invasive stimulation such as tDCS and TMS within 6 weeks; 4. In addition to conventional behavioral training, has taken psychotropic drugs for mental disorders; 5. Has not signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
Alpha Power;Electroencephalogram microstates;

Secondary

MeasureTime frame
Behavioral scale score;

Countries

China

Contacts

Public ContactNan Liu

Ningbo Rehabilitation Hospital

953092491@qq.com+86 574 8775 0587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026